What does the Site Network seek to accomplish?

VACCELERATE's site network aims to accelerate clinical development of COVID-19 vaccines for all populations and risk groups. The network database allows for a Europe-wide mapping of experienced clinical trial sites interested in conducting COVID-19 vaccine trials.
The Site Network uses its database to put individual sites in contact with clinical trial sponsors, matching the characteristics of each site with the specific requirements of an individual trial.
It acts as an information broker or matchmaker between interested sites and sponsors, it is not a governing or management body for trial conduct. The network interacts with established research networks but also with clinical trial sites not affiliated with a network.

The network thereby intends to boost the conduct of clinical trials of any scale across country borders in specific populations and risk groups that are not the focus of ongoing phase III trials. There is no upfront limitation on study design: Studies may be head-to-head interventional or observational, on short-term or long-term outcomes, focusing on very small populations or else. Any sponsor from academia, small or medium enterprises (SME), biotech or pharmaceutical industry is welcome to contact the Site Network. In the long term, it is designed to roll out vaccine trials in indications beyond COVID-19.